Koah ve astımda atak; [KOAH ve astımda atak]

Simple item page
dc.contributor.authorYildirim N.
dc.contributor.authorDemir T.
dc.contributor.authorGemicioğlu B.
dc.contributor.authorKiyan E.
dc.contributor.authorOğuzülgen K.
dc.contributor.authorPolatli M.
dc.contributor.authorSaryal S.
dc.contributor.authorSayiner A.
dc.contributor.authorYorgancioğlu A.
dc.contributor.authorBavbek S.
dc.contributor.authorÇelik G.E.
dc.contributor.authorGünen H.
dc.contributor.authorMungan D.
dc.contributor.authorŞen E.
dc.contributor.authorTürktaş H.
dc.contributor.authorYildiz F.
dc.date.accessioned2024-07-22T08:13:01Z
dc.date.available2024-07-22T08:13:01Z
dc.date.issued2015
dc.description.abstractChronic obstructive pulmonary disease (COPD) and asthma are airway diseases with acute exacerbations. Natural course of both disease are affected by exacerbations. COPD exacerbations may be caused by infections and other causes; indoor and outdoor pollution, cardiovascular diseases, asthma-COPD overlap syndrome, COPD- obstructive sleep apnea syndrome, pulmonary embolism, gastro-oesophageal reflux, anxiety-depression, pulmonary hypertension. Exposure to triggering factors, viral infections, treatment insufficiency may cause asthma exacerbations. Smoking cessations, prevention of infections, long-acting anticholinergics, long-acting β2 agonists, inhaled corticosteroids, phosphodiesterase-4 inhibitors, mucolytics, prophilactic antibiotics can be effective on the prevention of COPD exacerbations. Asthma exacerbations may be decreased by the avoidance of allergens, viral infections, occupational exposures, airpollution, treatment of comorbid diseases. Effective treatment of asthma is required to prevent asthma exacerbations. Inhaled steroids and combined treatments are the most effective preventive therapy for exacerbations. Patient education and cooperation is an element of the preventive measures for asthma attacks. Compliance to therapy, inhalation techniques, written asthma plans are required. The essential of COPD and asthma exacerbation treatment is bronchodilator therapy. Steroids are also implemented to the therapy, targeting the inflammation. Specific treatments of the cause (infection, airpollution, pulmonary embolism etc.) should be administered. © 2015, Ankara University. All rights reserved.
dc.identifier.DOI-ID10.5578/tt.8975
dc.identifier.issn04941373
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16258
dc.language.isoTurkish
dc.publisherAnkara University
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectAdministration, Inhalation
dc.subjectAdrenal Cortex Hormones
dc.subjectAnti-Bacterial Agents
dc.subjectAsthma
dc.subjectBronchodilator Agents
dc.subjectDisease Progression
dc.subjectExpectorants
dc.subjectHumans
dc.subjectInflammation
dc.subjectPulmonary Disease, Chronic Obstructive
dc.subjectbeta 2 adrenergic receptor stimulating agent
dc.subjectcorticosteroid
dc.subjectmucolytic agent
dc.subjectphosphodiesterase IV inhibitor
dc.subjectantiinfective agent
dc.subjectbronchodilating agent
dc.subjectcorticosteroid
dc.subjectexpectorant agent
dc.subjectanxiety
dc.subjectArticle
dc.subjectasthma
dc.subjectchronic obstructive lung disease
dc.subjectdepression
dc.subjectdisease association
dc.subjectdisease exacerbation
dc.subjectdisease severity
dc.subjecthuman
dc.subjectlung embolism
dc.subjectmortality
dc.subjectpulmonary hypertension
dc.subjectsleep disordered breathing
dc.subjectasthma
dc.subjectdisease course
dc.subjectinflammation
dc.subjectinhalational drug administration
dc.subjectpathology
dc.subjectPulmonary Disease, Chronic Obstructive
dc.titleKoah ve astımda atak; [KOAH ve astımda atak]
dc.typeArticle

Files

Collections

Scopus Koleksiyonu